The Joint (JYNT)
(Delayed Data from NSDQ)
$11.46 USD
+0.30 (2.69%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $11.46 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth B Momentum C VGM
Price, Consensus and EPS Surprise
JYNT 11.46 +0.30(2.69%)
Will JYNT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JYNT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JYNT
The Joint (JYNT) Forays Into San Francisco Chiropractic Market
The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates
JYNT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine
Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues
Other News for JYNT
SUCCESS Magazine Names The Joint Chiropractic one of the Top 50 Franchises
The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference
The Joint Chiropractic Opens First Location in San Francisco
Joint (JYNT) Receives a Hold from Maxim Group
Joint reports mixed Q2 results; reaffirms FY24 outlook